FDA Streamlines Review Pathway for Certain Glucose Monitoring DevicesByRyan BlackMarch 28th 2018Under Commissioner Scott Gottlieb, MD, the agency has made a concerted effort to move towards a less cumbersome, technology-friendly, risk-based approach.
Gottlieb Announces More Regulatory Updates to Encourage Device InnovationByRyan BlackDecember 11th 2017“Imagine the benefits of a more efficient and transparent pathway,” the FDA Commissioner wrote in a new blog post.